These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 4668919)

  • 1. [Retention of medium sized molecules in uremic serum].
    Dall'aglio P; Buzio C; Cambi V; Arisi L; Migone L
    Proc Eur Dial Transplant Assoc; 1972; 9():409-16. PubMed ID: 4668919
    [No Abstract]   [Full Text] [Related]  

  • 2. [Control by means of Computer control of the hematochemical picture in chronic uremic patients undergoing periodic hemodialysis treatment].
    Novario PG; Pagliano B; Denti E; Segoloni G; Piccoli G; Vercellone A; Coppo R
    Minerva Nefrol; 1974; 21(5):347-59. PubMed ID: 4467056
    [No Abstract]   [Full Text] [Related]  

  • 3. The removal of uremic small and middle molecules and free amino acids by carbon hemoperfusion.
    Oulès R; Asaba H; Neuhäuser M; Yahiel V; Gunnarsson B; Bergström J; Fürst P
    Trans Am Soc Artif Intern Organs; 1977; 23():583-90. PubMed ID: 910385
    [No Abstract]   [Full Text] [Related]  

  • 4. Hemoperfusion results in uremia.
    Gelfand MC; Winchester JF
    Clin Nephrol; 1979 Feb; 11(2):107-10. PubMed ID: 378488
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical evaluation of the disc cone dialyzer.
    Steinmuller S; Horn E; Hamilton R; Bluemle LW; Henderson L
    Trans Am Soc Artif Intern Organs; 1971; 17():273-8. PubMed ID: 5158104
    [No Abstract]   [Full Text] [Related]  

  • 6. HPLC study of uremic fluids related to optical dialysis adequacy monitoring.
    Lauri K; Tanner R; Jerotskaja J; Luman M; Fridolin I
    Int J Artif Organs; 2010 Feb; 33(2):96-104. PubMed ID: 20306436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uremic middle molecules.
    Bergström J; Fürst P
    Clin Nephrol; 1976 Apr; 5(4):143-52. PubMed ID: 1277596
    [No Abstract]   [Full Text] [Related]  

  • 8. Behavior of non-protein-bound and protein-bound uremic solutes during daily hemodialysis.
    Fagugli RM; De Smet R; Buoncristiani U; Lameire N; Vanholder R
    Am J Kidney Dis; 2002 Aug; 40(2):339-47. PubMed ID: 12148107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serum levels of medium-sized molecules in children with chronic kidney failure under conditions of short-term hemodialysis].
    Scigalla P; Gudim VI; Noack C; Devaux S; Grossmann P
    Z Urol Nephrol; 1980 Dec; 73(12):915-22. PubMed ID: 7223091
    [No Abstract]   [Full Text] [Related]  

  • 10. [Middle molecules separation from uraemic serum (author's transl)].
    Dall'aglio P; Buzio C; Gardini GP; Migone L
    Ateneo Parmense Acta Biomed; 1975; 46(5):331-44. PubMed ID: 1236694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemodiafiltration.
    Sprenger KB
    Life Support Syst; 1983; 1(2):127-36. PubMed ID: 6679009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Middle molecule accumulation in uremia: an "extra uremic factor".
    Oulès R; Emond C; Claret G; Branger B; Mion H; Mion C
    Artif Organs; 1981; 4 Suppl():177-83. PubMed ID: 7295089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum middle molecule levels in uremia during long term intermittent hemoperfusions with the acac (coated charcoal) microcapsule artificial kidney.
    Chang TM; Migchelsen M; Coffey JF; Stark A
    Trans Am Soc Artif Intern Organs; 1974; 20A():364-71. PubMed ID: 4217485
    [No Abstract]   [Full Text] [Related]  

  • 14. [Developmental tendencies of hemadsorption in uremia treatment].
    Falkenhagen D; Holtz M; Ahrenholz P; Esther G; Osten B; Klinkmann H
    Z Gesamte Inn Med; 1980 Sep; 35(17):Suppl 69-73. PubMed ID: 7467587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Removal of uremic waste metabolites from the intestinal tract by encapsulated carbon and oxidized starch.
    Sparks RE; Mason NS; Meier PM; Litt MH; Lindan O
    Trans Am Soc Artif Intern Organs; 1971; 17():229-38. PubMed ID: 5158097
    [No Abstract]   [Full Text] [Related]  

  • 16. Microcapsule artificial kidney and medium molecular weight clearance.
    Chang TM
    Proc Eur Dial Transplant Assoc; 1972; 9():568-74. PubMed ID: 4668931
    [No Abstract]   [Full Text] [Related]  

  • 17. Utilization of adsorbing materials for uremic blood purification.
    Denti E
    Biomater Med Devices Artif Organs; 1974; 2(3):295-300. PubMed ID: 4458819
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of oral essential amino acids and their ketoanalogues on children receiving regular haemodialysis.
    Bulla M; Bremer HJ; Ronda-Vildozola R; Roth B
    Int J Pediatr Nephrol; 1986; 7(2):73-80. PubMed ID: 3721728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term evaluation of charcoal hemoperfusion combined with dialysis in uremic patients.
    Winchester JF; Apiliga MT; Kennedy AC
    Kidney Int Suppl; 1976 Dec; (7):S315-9. PubMed ID: 1070554
    [No Abstract]   [Full Text] [Related]  

  • 20. [Studies on the significance of middle molecular retention products as uremia toxins].
    Goubeaud G; Leber HW; Schott HH
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1244-6. PubMed ID: 611827
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.